Report cover image

Hummingbird Diagnostics GmbH - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Mar 29, 2024
Length 37 Pages
SKU # GBDT18694776

Description

Summary


Hummingbird Diagnostics GmbH (Hummingbird) is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates, and analyzes genomic biomarkers especially derived from body fluid samples. It offers multilevel biomarker services and solutions. Hummingbird’s services comprise DNA and RNA extraction services, validation of biomarker candidates and quantitative analysis, microarray services and bioinformatic services, among others. Its products find applications in the treatment of cancer, chronic inflammatory diseases, cardiovascular diseases, and infectious disease. The company caters to pharmaceutical, biotech industry and academic life science customers. Hummingbird is headquartered in Heidelberg, Baden-Wuerttemberg, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Hummingbird Diagnostics GmbH
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

37 Pages
Hummingbird Diagnostics GmbH Company Overview
Hummingbird Diagnostics GmbH Company Snapshot
Hummingbird Diagnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
Hummingbird Diagnostics GmbH – Pipeline Analysis Overview
Hummingbird Diagnostics GmbH - Key Facts
Hummingbird Diagnostics GmbH - Major Products and Services
Hummingbird Diagnostics GmbH Pipeline Products by Development Stage
Hummingbird Diagnostics GmbH Ongoing Clinical Trials by Trial Status
Hummingbird Diagnostics GmbH Pipeline Products Overview
Companion Diagnostic Test - Bladder Cancer
Companion Diagnostic Test - Bladder Cancer Product Overview
Diagnostic Test - Acute Myocardial Infarction
Diagnostic Test - Acute Myocardial Infarction Product Overview
Diagnostic Test - Alzheimer's Disease
Diagnostic Test - Alzheimer's Disease Product Overview
Diagnostic Test - Breast Cancer
Diagnostic Test - Breast Cancer Product Overview
Diagnostic Test - Cancer Panel
Diagnostic Test - Cancer Panel Product Overview
Diagnostic Test - Heart Failure
Diagnostic Test - Heart Failure Product Overview
Diagnostic Test - IBD
Diagnostic Test - IBD Product Overview
Diagnostic Test - Melanoma
Diagnostic Test - Melanoma Product Overview
Diagnostic Test - Multiple Sclerosis
Diagnostic Test - Multiple Sclerosis Product Overview
Diagnostic Test - NSCLC
Diagnostic Test - NSCLC Product Overview
Diagnostic Test - Parkinson's Disease
Diagnostic Test - Parkinson's Disease Product Overview
miLung Blood Test
miLung Blood Test Product Overview
miLung Blood Test Clinical Trial
Hummingbird Diagnostics GmbH - Key Competitors
Hummingbird Diagnostics GmbH - Key Employees
Hummingbird Diagnostics GmbH - Locations And Subsidiaries
Head Office
Recent Developments
Hummingbird Diagnostics GmbH, Recent Developments
Jan 23, 2024: Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer
Oct 25, 2023: Hummingbird Diagnostics to Unveil Pioneering Alzheimer's Disease Biomarker Research at CTAD Conference
Jul 11, 2023: Hummingbird Diagnostics Announces Publication of miLung Small RNA-Based Blood Test for Early Detection of Lung Cancer in the Journal of Thoracic Oncology
May 31, 2023: Hummingbird Diagnostics to present poster on miLung small RNA-Based Blood Test at the ASCO 2023 Annual Meeting
Jun 23, 2022: Hummingbird Diagnostics publishes study of miRisk as a predictor of immunotherapy efficacy in advanced-stage NSCLC
Mar 31, 2022: Hummingbird Diagnostics announces publication of study on the utility of miRisk, a blood-based microRNA analysis, to predict overall survival for advanced non-small cell lung cancer in npj Precision Oncology
Apr 22, 2020: SkylineDx launches melanoma test in United States to support cancer care
Dec 14, 2015: Validation of Blood-based MiRNAs for Early Diagnosis of Lung Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Hummingbird Diagnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Hummingbird Diagnostics GmbH Pipeline Products by Equipment Type
Table 3: Hummingbird Diagnostics GmbH Pipeline Products by Indication
Table 4: Hummingbird Diagnostics GmbH, Key Facts
Table 5: Hummingbird Diagnostics GmbH, Major Products and Services
Table 6: Hummingbird Diagnostics GmbH Number of Pipeline Products by Development Stage
Table 7: Hummingbird Diagnostics GmbH Pipeline Products Summary by Development Stage
Table 8: Hummingbird Diagnostics GmbH Ongoing Clinical Trials by Trial Status
Table 9: Hummingbird Diagnostics GmbH Ongoing Clinical Trials Summary
Table 10: Companion Diagnostic Test - Bladder Cancer - Product Status
Table 11: Companion Diagnostic Test - Bladder Cancer - Product Description
Table 12: Diagnostic Test - Acute Myocardial Infarction - Product Status
Table 13: Diagnostic Test - Acute Myocardial Infarction - Product Description
Table 14: Diagnostic Test - Alzheimer's Disease - Product Status
Table 15: Diagnostic Test - Alzheimer's Disease - Product Description
Table 16: Diagnostic Test - Breast Cancer - Product Status
Table 17: Diagnostic Test - Breast Cancer - Product Description
Table 18: Diagnostic Test - Cancer Panel - Product Status
Table 19: Diagnostic Test - Cancer Panel - Product Description
Table 20: Diagnostic Test - Heart Failure - Product Status
Table 21: Diagnostic Test - Heart Failure - Product Description
Table 22: Diagnostic Test - IBD - Product Status
Table 23: Diagnostic Test - IBD - Product Description
Table 24: Diagnostic Test - Melanoma - Product Status
Table 25: Diagnostic Test - Melanoma - Product Description
Table 26: Diagnostic Test - Multiple Sclerosis - Product Status
Table 27: Diagnostic Test - Multiple Sclerosis - Product Description
Table 28: Diagnostic Test - NSCLC - Product Status
Table 29: Diagnostic Test - NSCLC - Product Description
Table 30: Diagnostic Test - Parkinson's Disease - Product Status
Table 31: Diagnostic Test - Parkinson's Disease - Product Description
Table 32: miLung Blood Test - Product Status
Table 33: miLung Blood Test - Product Description
Table 34: miLung Blood Test - Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung Early Detection of Lung Cancer Based on Small RNA Signatures - Boston II
Table 35: Hummingbird Diagnostics GmbH, Key Employees
Table 36: Glossary
List of Figures
Figure 1: Hummingbird Diagnostics GmbH Pipeline Products by Equipment Type
Figure 2: Hummingbird Diagnostics GmbH Pipeline Products by Development Stage
Figure 3: Hummingbird Diagnostics GmbH Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us